Eddy S. Leman

881 total citations
21 papers, 542 citations indexed

About

Eddy S. Leman is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Eddy S. Leman has authored 21 papers receiving a total of 542 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Pulmonary and Respiratory Medicine and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Eddy S. Leman's work include Prostate Cancer Treatment and Research (7 papers), Nuclear Structure and Function (4 papers) and RNA Research and Splicing (4 papers). Eddy S. Leman is often cited by papers focused on Prostate Cancer Treatment and Research (7 papers), Nuclear Structure and Function (4 papers) and RNA Research and Splicing (4 papers). Eddy S. Leman collaborates with scholars based in United States, Japan and Germany. Eddy S. Leman's co-authors include Robert H. Getzenberg, Allen C. Gao, Wei Lou, Zhaohui Ni, Mark L. Gonzalgo, Julie A. Arlotti, Masaaki Kasai, Donald Defranco, Robert Friedman and Rajiv Dhir and has published in prestigious journals such as The Journal of Urology, Journal of Cellular Biochemistry and The Prostate.

In The Last Decade

Eddy S. Leman

21 papers receiving 527 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eddy S. Leman United States 13 315 184 114 106 91 21 542
Orsolya Csuka Hungary 17 351 1.1× 283 1.5× 77 0.7× 127 1.2× 77 0.8× 48 713
Kyoung Eun Baek South Korea 13 432 1.4× 218 1.2× 69 0.6× 109 1.0× 54 0.6× 18 633
Jean‐Claude Marshall United States 18 440 1.4× 251 1.4× 112 1.0× 87 0.8× 94 1.0× 31 782
J. Kilian Mellon United Kingdom 13 484 1.5× 289 1.6× 98 0.9× 209 2.0× 40 0.4× 16 714
Maria Grazia Prisco Italy 16 310 1.0× 316 1.7× 79 0.7× 117 1.1× 53 0.6× 22 761
William Hankey United States 12 446 1.4× 137 0.7× 231 2.0× 162 1.5× 67 0.7× 24 664
Ilaria De Stefano Italy 15 316 1.0× 163 0.9× 80 0.7× 69 0.7× 63 0.7× 29 631
Dimitra Tsavachidou United States 10 395 1.3× 180 1.0× 203 1.8× 241 2.3× 28 0.3× 15 703
Yves Communal France 14 328 1.0× 149 0.8× 126 1.1× 146 1.4× 31 0.3× 23 669
Donkena Krishna Vanaja United States 9 542 1.7× 92 0.5× 232 2.0× 147 1.4× 28 0.3× 11 721

Countries citing papers authored by Eddy S. Leman

Since Specialization
Citations

This map shows the geographic impact of Eddy S. Leman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eddy S. Leman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eddy S. Leman more than expected).

Fields of papers citing papers by Eddy S. Leman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eddy S. Leman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eddy S. Leman. The network helps show where Eddy S. Leman may publish in the future.

Co-authorship network of co-authors of Eddy S. Leman

This figure shows the co-authorship network connecting the top 25 collaborators of Eddy S. Leman. A scholar is included among the top collaborators of Eddy S. Leman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eddy S. Leman. Eddy S. Leman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leman, Eddy S., Wei Huang, Humberto Contreras-Trujillo, et al.. (2012). 1072 INHIBITION OF BLADDER CANCER CELL GROWTH BY TREATMENT WITH SYNTHETICALLY DERIVED ANTI-CANCER PEPTOIDS. The Journal of Urology. 187(4S). 2 indexed citations
2.
Gonzalgo, Mark L. & Eddy S. Leman. (2010). Prognostic features and markers for testicular cancer management. Indian Journal of Urology. 26(1). 76–76. 21 indexed citations
3.
Inoue, Takahiro, Atsushi Maeno, C. Conover Talbot, et al.. (2009). Purine‐rich element binding protein (PUR) α induces endoplasmic reticulum stress response, and cell differentiation pathways in prostate cancer cells. The Prostate. 69(8). 861–873. 10 indexed citations
4.
Leman, Eddy S., Ahmed Magheli, Koh Meng Aw Yong, et al.. (2009). Identification of nuclear structural protein alterations associated with seminomas. Journal of Cellular Biochemistry. 108(6). 1274–1279. 27 indexed citations
5.
Leman, Eddy S. & Robert H. Getzenberg. (2009). Biomarkers for prostate cancer. Journal of Cellular Biochemistry. 108(1). 3–9. 68 indexed citations
6.
7.
Leman, Eddy S., Ahmed Magheli, Grant W. Cannon, et al.. (2008). ANALYSIS OF A SECOND EPCA-2 EPITOPE AS A SERUM TEST FOR PROSTATE CANCER. The Journal of Urology. 179(4S). 704–704. 3 indexed citations
8.
Walgenbach‐Brünagel, Gisela, Bettina Burger, Eddy S. Leman, et al.. (2007). The use of a colon cancer associated nuclear antigen CCSA‐2 for the blood based detection of colon cancer. Journal of Cellular Biochemistry. 104(1). 286–294. 17 indexed citations
9.
Leman, Eddy S. & Robert H. Getzenberg. (2007). Nuclear structure as a source of cancer specific biomarkers. Journal of Cellular Biochemistry. 104(6). 1988–1993. 29 indexed citations
10.
Leman, Eddy S., Grant W. Cannon, Lori J. Sokoll, et al.. (2007). 1431: Further Analysis of Serum Based EPCA-2 as a Specific Prostate Cancer Associated Biomarker. The Journal of Urology. 177(4S). 472–472. 1 indexed citations
11.
Leman, Eddy S., Grant W. Cannon, Lori J. Sokoll, et al.. (2006). 852: EPCA-2: A Highly Specific Serum Marker for Prostate Cancer. The Journal of Urology. 175(4S). 275–275. 2 indexed citations
12.
Leman, Eddy S., Julie A. Arlotti, Rajiv Dhir, & Robert H. Getzenberg. (2003). Vitamin D and androgen regulation of prostatic growth. Journal of Cellular Biochemistry. 90(1). 138–147. 17 indexed citations
13.
Leman, Eddy S., et al.. (2003). Nuclear matrix localization of high mobility group protein I(Y) in a transgenic mouse model for prostate cancer. Journal of Cellular Biochemistry. 88(3). 599–608. 21 indexed citations
14.
Leman, Eddy S., et al.. (2003). Regulation of Androgen and Vitamin D Receptors by 1,25-Dihydroxyvitamin D 3 in Human Prostate Epithelial and Stromal Cells. The Journal of Urology. 170(1). 235–240. 9 indexed citations
15.
Leman, Eddy S. & Robert H. Getzenberg. (2002). Effects of 1,25‐dihydroxyvitamin D3 on the distribution of androgen and vitamin D receptors in human prostate neonatal epithelial cells. Journal of Cellular Biochemistry. 88(3). 609–622. 5 indexed citations
16.
Leman, Eddy S. & Robert H. Getzenberg. (2002). Nuclear matrix proteins as biomarkers in prostate cancer. Journal of Cellular Biochemistry. 86(2). 213–223. 27 indexed citations
17.
Leman, Eddy S., Julie A. Arlotti, Rajiv Dhir, Norman M. Greenberg, & Robert H. Getzenberg. (2002). Characterization of the nuclear matrix proteins in a transgenic mouse model for prostate cancer. Journal of Cellular Biochemistry. 86(2). 203–212. 5 indexed citations
18.
Leman, Eddy S., Betty F. Sisken, Stephen G. Zimmer, & Kimberly W. Anderson. (2001). Studies of the interactions between melatonin and 2 Hz, 0.3 mT PEMF on the proliferation and invasion of human breast cancer cells. Bioelectromagnetics. 22(3). 178–184. 15 indexed citations
19.
Ni, Zhaohui, Wei Lou, Eddy S. Leman, & Allen C. Gao. (2000). Inhibition of constitutively activated Stat3 signaling pathway suppresses growth of prostate cancer cells.. PubMed. 60(5). 1225–8. 184 indexed citations
20.
Konety, Badrinath R., et al.. (2000). IN VITRO AND IN VIVO EFFECTS OF VITAMIN D (CALCITRIOL) ADMINISTRATION ON THE NORMAL NEONATAL AND PREPUBERTAL PROSTATE. The Journal of Urology. 164(5). 1812–1818. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026